A Kid You Need to Know

Pat Pedraja is in remission from acute lymphocytic leukemia (ALL), a disease he's been fighting since he was 10. He got involved when he heard about a shortage of bone marrow donors, especially among Latinos and African-Americans. Pat is half Cuban; within days, he decided to help. He and his family logged more than 100,000 miles in a used RV dubbed the Donormobile, speaking in front of school assemblies and civic groups about the need for marrow volunteers. Pat's speaking engagements and Web site, drivingfordonors.com, have signed up more than 14,000 people to be potential marrow donors.



Pat raised funds for his cause through one of the strangest - and boldest - advertising schemes ever created: he sold the rights to his bald head for local corporate advertising in every city he visited. "Pat had lost his hair because of the treatments," explained his mother. "So he auctioned space on his forehead on eBay and found a bidder for $5,000."



According to Andrews, all kinds of companies since then have paid for the privilege of their logo temporarily tattooed on Pat's head. More recently, Pat won the 2008 Do Something Award, from the teen-action group Do Something.org. One of the prizes was his picture on bags of Doritos chips. Check out Pat's new Web site: www.theplanetus.com.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap